Utah Medical Products (UTMD) Q3 Results Highlight Revenue Pressure Beneath Strong Margins
Utah Medical: Q3 Earnings Snapshot
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
Utah Medical Products Q3 EPS $0.88 Up From $0.82 YoY, Sales $8.621M Down From $9.812M YoY
Utah Medical Products, Inc. Extends Tender Offer
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
Utah Medical Products, Inc. Commences Tender Offer
Utah Medical Products Inc's Dividend Analysis
UTMD Announces Self-Tender for 20% of Its Shares
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
Utah Medical Products: Healthy Cash Holdings, But Declining Revenue Is A Cause For Concern
Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
Utah Medical Products Q2 EPS $0.84 Down From $0.94 YoY, Sales $8.529M Down From $9.953M YoY
Utah Medical Products: I Can't Upgrade Shares Until Sales Stabilize
Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
Utah Medical Products Q1 EPS $0.82 Down From $0.92 YoY, Sales $8.722M Down From $9.710M YoY
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.